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ABSTRACT 
 
Purpose: To assess whether adapted motivational interviewing has any impact on the proportion of 
participants who subsequently underwent surgery or laser treatment for glaucoma.  
 
Methods: A single site randomized controlled trial in Bauchi, Nigeria. Participants were new patients 
with a confirmed diagnosis of primary open angle glaucoma in one or both eyes, where surgery or 
laser was recommended. Intervention was a session of motivational interviewing adapted for 
glaucoma and the local context, using an interview guide based on local qualitative research. 
Participants were randomly allocated to intervention or usual care. Usual care was routine 
explanation by an ophthalmologist and an educational pamphlet. After the interview, a 12-item 
Working Alliance Inventory questionnaire was administered to patient-interviewer pairs to assess the 
collaborative relationship.  
 
Results: 276 glaucoma patients participated; 70% males. 135 (49%) were assigned to adapted 
motivational interviewing and 141 to usual care. All received the intervention as allocated. Uptake 
(i.e., the proportion who underwent treatment) of laser or surgery in the motivational interviewing 
group was 52% compared with 45% in the usual care group (risk difference 7.2%, 95% confidence 
interval -4.5-18.9%). Mean Working Alliance Inventory scores were 68.0 for interviewers and 68.5 for 
participants with a combined reliability coefficient of 93.9% (i.e., high internal consistency and 
reliability). 
 
Conclusion: We observed only a small increase in the uptake of surgery or laser with motivational 
interviewing compared with usual care which was not statistically significant. Although only 1 in 2 
patients accepted surgery or laser in this trial, this is a much higher proportion than in other studies.  
 
Key words: Glaucoma, Motivational interviewing, Treatment uptake, Africa 
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INTRODUCTION 
Glaucoma is a public health problem in Africa, with the prevalence of blindness due to glaucoma 
higher than in other regions, with an aggressive course,1 2  higher rates among young people3, and 
late presentation4 on account of lack of primary eye care and awareness, reduced access to 
treatment and low awareness of the risk of having primary open angle glaucoma (POAG)5.  Health 
facilities are also poorly equipped6 with inadequate human resources and limited treatment options. 
Exacerbating these problems is poor acceptance of and adherence to trabeculectomy, the preferred 
treatment in Africa,7, 8 as patients experience no immediate visual benefit and are fearful of the 
procedure.9 For prevention of blindness in glaucoma there are modifiable factors such as increasing 
awareness by education,10,11 and encouraging change in acceptance and adherence to treatment 
and follow up.  
In this study motivational interviewing (MI) was selected as the intervention to enhance uptake of 
treatment (i.e., they accept and actually undergo treatment).  Motivational interviewing has been 
described as “a collaborative, goal-oriented style of communication with particular attention to the 
language of change. It is designed to strengthen personal motivation for and commitment to a 
specific goal by eliciting and exploring the person’s own reasons for change within an atmosphere of 
acceptance and compassion”.12  Guidance includes giving information whilst honouring patient 
autonomy. Motivational interviewing was originally developed for addictive behaviours,13 and a wide 
range of applications have been developed.12  
In this study MI was adapted as an approach to counselling for use in patients with glaucoma, and 
hereafter is referred to as adapted motivational interviewing for glaucoma (AMIG). The purpose of the 
trial was to assess whether AMIG has an impact on the uptake of surgery or laser treatment by 
glaucoma patients. The hypothesis tested was that AMIG increases the uptake of treatment (surgery 
or laser treatment) among glaucoma patients in comparison with enhanced usual care.  
Setting 
The trial was undertaken in the eye clinic of Abubakar Tafawa Balewa University Teaching Hospital 
(ATBUTH), Bauchi State, in the North East of Nigeria. More than 80% of the catchment population of 
approximately four million people live in rural areas or live on less than one United States Dollar 
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(USD) per day, with low levels of literacy (males 53%, females 13%).14 All new patients attending the 
ATBUTH eye clinic are allocated a unique medical record number and are given a green registration 
card, which includes the dates of clinic attendance, registration and surgical appointments. Surgery is 
performed twice a week, and if lists are cancelled in advance patients are notified and given another 
date to attend. It is extremely rare for patients to attend for surgery on any date other than the date 
given. All operations are recorded in the operating theatre register, giving details of their name, age, 
sex, hospital record number and surgical procedure. A register of all new glaucoma patients was 
initiated before the trial started. 
 
METHODS 
 
The definition of POAG used in the trial followed that recommended by Foster in 200215 which has 
been applied to normative data from the Nigeria National Blindness and Low Vision Survey.16 The 
values which defined glaucoma were IOP greater than 26mmHg (the 97.5th percentile for IOP from 
the Nigeria Blindness Survey), and a vertical cup disc ratio (VCDR) of more than 0.7 (the 97.5th 
percentile for VCDR from the Nigeria Blindness Survey) with visual field loss consistent with 
glaucoma in one or both eyes.  
Trial design  
This was a single site effectiveness trial with 1:1 allocation to evaluated intervention or enhanced 
usual care.17 No changes were made to the protocol after the trial started. The trial is reported in 
accordance with the CONSORT statement.18,19 The full protocol has been published and can be 
assessed at http://trialsjournal.biomedcentral.com/articles/10.1186/1745-6215-15-149. The trial is 
registered at Controlled-Trials.com, registration number ISRCTN79330571, available at the following 
URL. 
http://www.isrctn.com/ISRCTN79330571?q=abdull&filters=&sort=&offset=1&totalResults=1&page=1
&pageSize=10&searchType=basic-search. 
 
Inclusion criteria: New patients (i.e., first attendance at ATBUTH) with a confirmed diagnosis of 
POAG in one or both eyes, where surgery or laser was recommended as the treatment of choice to 
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preserve vision. The surgeon decided which eye was most in need of urgent treatment. Other 
inclusion criteria included aged 17 years or above, ability to understand Hausa or English and lived 
within 200 km of the clinic. 
 
Exclusion criteria: Patients who had ocular comorbidities or systemic diseases that may 
contraindicate surgery or laser, communication problems such as profound deafness, previous ocular 
surgery (except cataract surgery), specific referral for glaucoma surgery, or lack of consent to 
participate. 
 
Intervention   
The intervention was a single session of MI adapted for the local context and language using a draft 
interview guide generated following a qualitative study.9 The principal researcher was trained in MI in 
Europe in two workshops and subsequently coached the two study interviewers. They worked 
together in pilot interviews until a satisfactory level of competence had been reached. The 
interviewers conducted all the interviews in a quiet room in the clinic, in the participant’s preferred 
language (Hausa or English). The interviewer engaged the participant by presenting an agenda for 
discussion which included awareness of glaucoma and the consequences of no treatment, 
acceptance of surgical treatment options, adherence to prescribed medication and follow up to 
monitor the eye pressure. Open-ended questions were asked, with active listening including 
reflections. The interviewers sought to understand the participant’s perspective in an empathic 
fashion and listened for evidence of change talk.  
 
Fidelity to MI (whether delivery adheres closely to the approach) can be assessed using the 
Motivational Interviewing Treatment Integrity code (MITI).20 The extent to which a collaborative 
relationship forms between interviewer and client is assessed using the Working Alliance Inventory 
(WAI)21 and high WAI scores given by interviewers and clients indicate greater connection between 
the two parties. The AMIG sessions sought to follow the spirit of MI, and were recorded. Interview 
sessions lasted 35 to 60 minutes. After the AMIG interview, the 12-item WAI Short Questionnaire 
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(WAI-SR) was administered to each participant and interviewer to assess the collaborative 
relationship.21  
Outcomes  
The primary outcome was the proportion of participants who accepted and underwent surgery or 
laser treatment (i.e., uptake) within two months of the date given for the procedure.  
 
Sample Size  
The sample size was calculated based on the primary outcome using the SAMPSI command in Stata 
14 statistical software (Stata/IC14.0; Stata Corp, College Station, TX, USA). Based on the pilot study, 
we anticipated that 35% of people in the control group would accept and undergo surgery or laser 
treatment within two months. A sample size of 137 in each arm was required to detect a 50% relative 
or 17.5% absolute increase in uptake (equivalent to an uptake of 52.5% in the intervention group) 
(power 0.8, alpha 0.05). The sample size of 137 was rounded up to 150 in each arm to allow for loss 
to follow-up. No subgroup or interim analyses were planned. 
 
Recruitment 
Eligible patients were identified for enrolment by the ophthalmologists who referred them to the 
Project Manager for recruitment. The Project Manager ensured that potential participants understood 
the information sheet and signed the consent form. They were given a unique study ID and 
demographic information, home address and telephone number collected to enable subsequent 
tracing.  
All participants were given a red card with their name, hospital medical record number and their trial 
ID. They were instructed to present this card to the Project Manager at every attendance at the clinic, 
and on presentation they were fast tracked through the system. Clinical examination, treatment 
recommendation, randomization, data collection and entry into the trial database were all undertaken 
on the same day.  
 
Randomisation 
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Sequence generation: A statistician, not at the project site, generated the randomization list using the 
randbetween function in Excel (Office 2013, Microsoft inc). Block randomization with variable block 
sizes was used to ensure balance in the groups over time, as the uptake of laser or surgery may 
fluctuate over time.  
Allocation concealment mechanism: The option of AMIG or no AMIG was printed on headed paper, 
signed and stamped off-site, in London by persons not involved in the trial. These were placed in 
sequentially numbered opaque envelopes in accordance with the randomization schedule, which 
were then sealed and stamped. A second similar procedure was followed to randomize those 
allocated to AMIG to either interviewer A or interviewer B. These envelopes were kept in a locked 
cupboard and were only opened when needed. 
 
Implementation:  Immediately after recruitment the next envelope in the sequence was opened to see 
if the patient was allocated to AMIG or not. The interviewers wrote the sequence number on the 
participant’s form and their unique ID number was written on the outside of the envelope and 
returned to a sealed locked container. The same processes were adopted for allocation to interviewer 
A or B. 
 
Procedures 
During the clinical consultation with the attending ophthalmologist before randomization, an 
explanation of glaucoma was given to all participants as well as the treatment options and 
prognosis.22 After explaining treatment options the ophthalmologist recommended one form of 
treatment, taking account of the severity of disease and socio-demographic variables. Usual care 
was enhanced by providing all participants in both groups with written information, in Hausa or 
English, about glaucoma. This written information was developed and pilot tested following interviews 
with glaucoma patients. The pamphlet, which was called the “Silent Thief”, contained images to 
represent visual field loss and conveyed simple messages. A copy of the pamphlet was also 
displayed at the entrance to the clinic. 
The date for surgery or laser was determined at the first consultation and name, age, sex, 
hospital medical record and procedure were entered into the operating list. Patients were informed of 
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the date orally and it was written on their red card. The date and type of surgery were recorded in the 
database. A separate tracing database was created containing the agreed date of surgery for each 
participant and a date two months after this date was generated automatically.    
Severity of glaucoma in the study eye was categorized as early, moderate, advanced or end 
stage, based on VCDR and visual field loss. The former was assessed subjectively by the 
ophthalmologist using direct or indirect ophthalmoscopy or with fundus photography with a DRS 
digital fundus camera (CentreVue SpA Padova, Italy). Visual fields were assessed using an Oculus 
Twinfield Visual field analyser (OCULUS Optikgeräte GmbH). Early glaucoma was defined as VCDR 
of less than 0.8 with very little to no visual field loss, moderate as a VCDR less than 0.8 with a visual 
field greater than 10 degrees, advanced as a VCDR of 0.8-0.9 with a visual field of approximately 5-
10 degrees and end stage was defined as a VCDR of 1.0, with a visual field of 5 degrees or less, 
including when no visual field could be recorded.  
 
Ascertainment of the primary outcome 
Every operating day the operating list was checked by the Project Manager to ascertain whether trial 
participants had attended for laser or surgery on the day allocated, by cross checking details in the 
operating book with those in the trial database. For those attending, the date and type of treatment  
performed were recorded. Participants who did not attend on the date allocated but who attended 
within the two month period were identified by presentation of their red cards to the Project Manager. 
 
Masking 
Only participants allocated to AMIG and the AMIG interviewers knew who had been allocated to 
AMIG. Participants were asked by the interviewers not to discuss whether they had had an interview 
with the Project Manager, ophthalmologists or other patients to avoid contamination and to maintain 
masking. In particular, the Project Manager, who was responsible for assessing the primary outcome, 
was masked to the treatment allocation.  
Data management 
Two databases were created in Epidata (EpiData Odense Denmark, EpiData Association, 2010-. 
Http://www.epidata.dk) with range and consistency checks. The Project Manager entered data into 
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the main trial database. Data were entered as soon as possible after recruitment, so that the ‘surgery 
date’ and ‘tracing date’ outputs could be generated. All data entries were double-checked by the lead 
researcher (MA). The second database, which was maintained by the interviewers, contained the 
unique ID, allocation status for AMIG and interviewer, and WAI data. The databases were maintained 
on separate password projected computers in different lockable offices. Random checks of the 
quality of data entry were regularly performed in Stata (Stata/IC14.0; Stata Corp, College Station, TX, 
USA).  
 
Data analyses 
The randomization code was broken only after analysis of the primary outcome, which was by 
intention to treat. There were no missing data on the primary outcome. We compared the proportion 
of people in the intervention and control group achieving the primary outcome (uptake of surgery or 
laser treatment) using  the risk ratio and the risk difference and report these two measures of effect 
with 95% confidence intervals (calculated using the ‘epitab’ command in Stata 14). Univariate and 
multivariable logistic regression analyses were performed to explore factors associated with 
undergoing surgery or laser treatment such as gender, age group, distance to hospital, education, 
occupation, mode of presentation, severity of disease, baseline IOP and interviewer. Analysis by 
interviewer was performed to explore whether the primary outcome varied with the interviewer 
performing AMIG. Post-hoc analysis of the primary outcome and WAI data was undertaken to 
compare outcomes and quality of the earlier and later AMIG interviews (first half versus second half).  
 
 
 
Working Alliance Inventory questionnaires for participants’ and interviewers’ ratings of the AMIG 
sessions were analyzed as total WAI scores and medians. Cronbach's alpha test was applied to 
participant and interviewer total scores to assess the level of correlation between scores. Data were 
also analysed to assess whether WAI scores for participants, and for interviewers, were associated 
with the primary outcome using median split WAI scores using Pearson chi square test.  
RESULTS 
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Recruitment was slower than anticipated due to civil unrest in North Eastern Nigeria (September 
2013 to September 2015). Only one eligible patient refused to participate (Figure 1). A total of 276 
glaucoma patients participated in the study. 135 (49%) were assigned to the intervention group and 
141 to the control group. All received the intervention as allocated. There were no major imbalances 
between the two groups at baseline (Table 1).  
 
Table 1. Baseline socio-demographic and ocular variables, by allocation arm 
 
In almost all patients (89% of the 276 participants) laser treatment was recommended, in 7% 
glaucoma surgery alone was recommended and in 4% a combination of cataract surgery with 
trabeculectomy or laser was recommended. Slightly more of the intervention group (93%) were 
recommended laser compared with the control group (84%) but this difference was not statistically 
significant.  When participants attended for treatment they were administered the treatment they 
preferred. All 133 treated patients underwent laser treatment by choice which was the treatment 
recommended in all but 13. 
Figure 1: Participant flow diagram showing enrolment of participants 
 
Outcomes  
Primary outcome 
Uptake of treatment in the AMIG group was 52% compared with 45% in the usual care group (Table 
2). The risk ratio was 1.2 (95% confidence interval (CI) 0.9-1.5) and the risk difference was 7.2% 
(95% CI 0-18.9%).   
 
Table 2: Results of primary outcome of the trial, uptake of surgery or laser 
 
The number of participants allocated to interviewer A was 68 and 67 to interviewer B. There was no 
significant difference in the uptake of treatment between interviewer A and interviewer B, being 46% 
for interviewer A and 54% for interviewer B (Pearson chi2(1): 0.9073; p = 0.34).  
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In the first 138 patients recruited (of the 276 total) the risk ratio was 1.1 (95% CI 0.8-1.5) and the risk 
difference was 2.8% (95% CI -13.8-19.5%). In the last 138 recruited the risk ratio was 1.3 (95% CI 
0.9-1.8) and the risk difference was 11.3% (95% CI -5.2-27.9%). There were no differences in 
interviewer and participant median WAI scores during the two time periods (69% and 71% vs 69% 
and 71% respectively). 
 
In univariate analysis, participants with either graduate/post graduate or informal education were 
more likely to undergo treatment than and those with no education (Pearson ch2, 15.16, p = 0.01). 
There were no other statistically significant predictors of uptake of treatment by socio-demographic or 
ocular variables in the univariate analyses. Education was also strongly predictive in the multivariable 
analysis (Table 3). 
Table 3: Multivariable regression analysis of factors affecting uptake of surgery or laser 
 
In the adjusted analysis (Table 3) the odds ratio for undergoing treatment was 1.6 (95% CI 0.9-2.8) 
but this was not statistically significant.  
Fidelity testing using MITI for English language sessions was planned, but was not possible because 
all interviews were conducted in local languages, Hausa or Pidgin English, which prevented formal 
coding.   
Analysis of Working Alliance Inventory scores 
Analysis of WAI showed similar scores for participants and interviewers overall and were similar for 
both interviewers (Table 4).   
 
Table 4: Correlation between participant and interviewer Working Alliance Inventory scores  
 
Analysis of WAI scores gave the same median split for participant and interviewer scores overall 
(median scores 70 for both). There were no statistically significant differences in the primary outcome 
by interviewer median split WAI scores.  
 
There were no harmful or unintended effects in either group. 
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DISCUSSION 
 
Participants in the AMIG arm underwent treatment at a higher rate than the usual care group (a 
difference of approximately 7%) but this difference could have arisen by chance. This is the first trial 
to use this counselling intervention for glaucoma in Africa, and the results do not support introduction 
of adapted MI into routine practice.  
 
The sample size calculation was based on a pilot study of 45 individuals in which there was an 
absolute difference of 12% between AMIG (47% uptake) and usual care (35% uptake) groups, but a 
difference of this magnitude may have occurred by chance as the sample size was small.17 In the 
main trial the observed risk difference does not exclude the possibility of a 19% difference. There 
was no difference in uptake of treatment by interviewer, which reflects the similarities in WAI scores.  
 
In this trial all participants underwent laser treatment, which was described as “computer light 
treatment”, probably because this term induces less fear than the term surgery.4 Laser treatment also 
does not require an inpatient stay, so reducing patient costs. Indeed, uptake of treatment for 
glaucoma has improved dramatically since laser treatment became available:  six years prior to the 
trial, when laser was not available, only 8% of 85 glaucoma patients offered surgery as the treatment 
of choice agreed to the procedure, and less than 2% finally underwent surgery4. Participants who 
underwent laser treatment in the trial may also have discussed their experiences with friends, family 
and community members, which increased the acceptability of laser treatment amongst those who 
subsequently attended the clinic, regardless of allocation. Other reasons for the higher than 
anticipated uptake of laser treatment in the usual care group could reflect improvements in the 
infrastructure, equipment, skills and motivation of trained staff since the pilot study, and the more 
informative educational pamphlet given to all participants.  
 
Cultural factors are relevant to the interpretation of these findings. Uptake of treatment was higher 
among participants with higher levels of education, as has been shown previously.23 However, 
uptake was not associated with severity of disease, even amongst those at imminent risk of 
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blindness. The reason for this finding is not clear, as it is not uncommon for patients with advanced or 
end stage disease to lose hope, as highlighted in our earlier study.9 Professionals, despite their 
higher level of education, had lower uptake of surgery or laser, which may reflect lack or time or a 
preference for topical treatment, which they can afford.   
 
We have no data on fidelity to MI, which if low, may also explain the lack of effect. Motivational 
interviewing is complex and may require more and better training and supervision than was possible 
in this effectiveness trial.24 The WAI data were not subject to linguistic restrictions, and the results 
showed encouragingly good concordance, although these self-reported data are subject to 
information bias. 
Follow up of participants for treatment and research purposes continues to be a major challenge in 
rural Africa where many glaucoma patients never return after the first visit. Low cost approaches 
such as text message reminders, that have been used to improve follow up in trabeculectomy 
patients, may be employed.25 
The findings of this trial may be generalisable to other clinics that treat patients with glaucoma in this 
area, and potentially also elsewhere in Africa. However, it may not be generalisable to the general 
population where there will be many more people with undiagnosed, earlier glaucoma who may react 
differently to AMIG.  
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